Document Detail


The use of cyclosporine in a boy with a prior episode of posterior encephalopathy.
MedLine Citation:
PMID:  15717165     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We report the case of a 12- year-old Japanese boy who was receiving cyclosporine (Cs A) for steroid-dependent nephrotic syndrome despite a prior episode of Cs A-associated posterior encephalopathy. At the third relapsing of nephrotic syndrome, Cs A was initiated. Eight days after the Cs A therapy, the boy was admitted to the University Hospital of Tsukuba because of generalized convulsion. Magnetic resonance imaging (MRI) showed hyperintense lesions involving the bilateral parieto-occipital region. Cs A was discontinued, and cyclophosphamide was started. The boy had a 6-month drug-free period after the cyclophosphamide treatment and then relapsed three more times in the following 5 months. As the prednisolone dosage could not be decreased to less than 2 mg/kg/48 h, the patient was re-challenged with Cs A 1 1/2 years later. Blood pressure and serum Cs A levels were measured frequently, an anti-hypertensive drug was given, and MRI was done four times to detect hyperintense lesions. He has been receiving Cs A for 9 months, and MRI has revealed no abnormalities. At the latest follow-up, dated 12 April 2004, he was in a remissive state of nephrotic syndrome. This is the first report of giving Cs A to a nephrotic child who had a previous history of Cs A-associated posterior encephalopathy.
Authors:
Chieko Nakahara; Naoyuki Hasegawa; Isho Izumi; Katsuyosi Kanemoto; Nobuaki Iwasaki
Related Documents :
11084845 - Moderate-dose intravenous immunoglobulin treatment of job's syndrome. case report.
12372955 - Nephrotic syndrome with portal, splenic and renal vein thrombosis. a case report.
18214715 - Nephrotic syndrome and acute renal failure in non-hodgkin lymphoplasmacytic lymphoma.
3021645 - The role of renal prostaglandin e as a possible modulator of cyclic amp production in n...
21993675 - Treatment with lenalidomide does not appear to increase the risk of leukemia progressio...
17643515 - C-reactive protein in acute coronary syndromes: a perfect trigger or an excellent indic...
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2005-02-17
Journal Detail:
Title:  Pediatric nephrology (Berlin, Germany)     Volume:  20     ISSN:  0931-041X     ISO Abbreviation:  Pediatr. Nephrol.     Publication Date:  2005 May 
Date Detail:
Created Date:  2005-04-19     Completed Date:  2005-07-06     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8708728     Medline TA:  Pediatr Nephrol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  657-61     Citation Subset:  IM    
Affiliation:
Department of Pediatrics, National Hospital Organization Mito Medical Center, Higashihara 3-2-1 Mito, 310-0035, Ibaraki, Japan. c.nakahara.d@mn.hosp.go.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Inflammatory Agents / administration & dosage
Child
Cyclosporine / administration & dosage*,  adverse effects
Humans
Immunosuppressive Agents / administration & dosage*,  adverse effects
Magnetic Resonance Imaging
Male
Nephrotic Syndrome / drug therapy*
Neurotoxicity Syndromes / etiology*,  pathology
Prednisolone / administration & dosage
Recurrence
Remission Induction
Chemical
Reg. No./Substance:
0/Anti-Inflammatory Agents; 0/Immunosuppressive Agents; 50-24-8/Prednisolone; 59865-13-3/Cyclosporine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The response to cyclophosphamide in steroid-sensitive nephrotic syndrome is influenced by polymorphi...
Next Document:  Glucose transporters in diabetic nephropathy.